Sort by:
- Doctors (22)
- Locations (18)
ON L6H 0J8, CA
Paul Sanghera, MD FRCSC
Contact Info
Office Hours
- Today
- 9:00AM - 5:00PM
Paul Sanghera, MD FRCSC
About Paul Sanghera, MD FRCSC
Dr. Paul Sanghera is a nationally renowned cataract and refractive surgeon. Having performed more than 25,000 intraocular and 30,000 laser surgeries across Canada, he is recognized as a leader in his field and a pioneer in the use of new technologies. His experience has afforded him the skill and knowledge to cater today’s cutting-edge surgeries to match every patient’s unique visual needs and improve their visual outcomes.
Having completed his bachelor’s degree and medical school at the University of Alberta, where he was on the dean’s list, Dr. Sanghera was also the recipient of numerous awards and scholarships, including the Opal Hess Memorial Scholarship and the Dr. AJ Pauly Bursary in Medicine. Additionally, he was cited as the highest ranked applicant to enter the MD Program in 1997. He then specialized in ophthalmology at the University of Toronto and went on to receive further post-graduate training in refractive laser surgery.
Dr. Sanghera has been actively involved in research since his residency, including a $10,000 research grant from the Glaucoma Research Society of Canada and numerous ongoing projects using state-of-the-art technologies in cataract surgery and intraocular lenses. He has also lectured both nationally and internationally at major ophthalmology conferences. He is currently a lecturer at the University of Toronto, on staff at Mount Sinai Hospital and Kensington Eye Institute, both in Toronto, as well as Stevenson Memorial Hospital in Alliston, ON. Dr. Sanghera is also actively involved in both resident and medical student education across the Greater Toronto Area.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.